S Equol Powder

Equol is an isoflavandiol metabolized from daidzein by human gut microbiota and exists as chiral isomers. S equol is the naturally occurring bioactive form produced in the human body. Research indicates that S-equol helps support physical comfort for perimenopausal women, contributes to mood relief and sleep maintenance, supports normal bone metabolism and helps preserve bone health after menopause. It also delivers antioxidant properties to assist skin collagen maintenance and offers nutritional support for lipid metabolism and vascular health. Consumable directly, S-equol does not rely on individual gut microbiota for conversion, making it suitable for people who cannot produce equol endogenously for dietary nutrition supplementation.

Commercially, S-equol is extensively formulated into dietary supplements targeting perimenopausal women, frequently combined with daidzein-rich soy isoflavones, collagen peptides and various vitamins. It is also used in oral anti-aging nutritional products and sparingly incorporated as an active ingredient in skincare formulations.

Healthkintai^® boasts more than ten years of R&D and manufacturing expertise in dietary supplement raw materials. We specialize in functional raw materials for women's health, with Bulk s equol powder as our core flagship product, available at a purity of ≥98%. Complete test documentation is provided to suit the development of various finished dietary supplements. We welcome clients worldwide to contact us at health@kintaibio.com for samples, technical data and quotations.

Equol exists as two enantiomers at the C-3 chiral center: S-equol and R-equol. Despite identical molecular formulas, their opposite spatial configurations produce distinct estrogen receptor (ER) binding profiles and transcriptional activities. S-equol is the exclusive endogenously produced enantiomer in humans, binds ERβ with high affinity, and has demonstrated benefits for menopausal symptoms and bone health, whereas R-equol has no endogenous source, shows weak overall receptor affinity, and is far less biologically active.

S Equol for Menopause

S-equol is a selective estrogen receptor modulator that preferentially binds to ERβ with high affinity, producing tissue-selective estrogen-like or anti-estrogenic biological effects at target sites such as the hypothalamus. It delivers mild estrogenic support when endogenous estrogen secretion is insufficient, and helps maintain hormonal homeostasis via competitive receptor binding when estrogen levels are elevated.

 

Enabled by this precise bidirectional regulatory mechanism, it acts on the vasomotor center. Clinical studies have demonstrated that it reduces the frequency of menopausal hot flashes by 58.7%, while alleviating multiple discomforts associated with menopause including sleep disturbances, mood swings and impaired cognitive function. Thanks to its high target selectivity for the ERβ receptor, it circumvents potential breast and endometrial health risks stemming from non-specific ERα activation in conventional hormone therapy, offering a scientifically viable option for women seeking natural and gentle approaches for menopausal management.

S Equol for Bone Health

S-equol preferentially activates estrogen receptor ERβ highly expressed in bone tissue, up-regulates osteoprotegerin (OPG) expression and reduces RANKL ligand levels, and inhibits NF-κB-driven osteoclast differentiation and excessive bone resorption. Meanwhile, it activates the Wnt/β-catenin and PI3K/Akt signaling pathways to support normal viability of osteoblasts and osteocytes and promote bone matrix formation.

 

In addition, S-equol neutralizes reactive oxygen species and alleviates oxidative stress and inflammatory damage induced by pro-inflammatory factors TNF-α and IL-6, bidirectionally regulating the physiological balance of human bone remodeling and helping slow bone mass loss.

 

These effects are supported by cell-based studies, animal experiments and partial human trial data. This ingredient has no medicinal efficacy and shall not be used to treat bone diseases.

S Equol for Heart Health

S-equol can selectively activate ERβ receptors highly expressed in vascular endothelial tissues, trigger PI3K/Akt signaling cascade, facilitate the production and release of nitric oxide (NO), and help maintain normal vasodilation. Meanwhile, it modulates the NF-κB signaling pathway to reduce the expression of pro-inflammatory factors such as TNF-α and IL-6, scavenge excess reactive oxygen species, inhibit low-density lipoprotein oxidation, and lessen the accumulation of oxidized lipids in vascular walls.

 

It supports healthy blood lipid profiles and improves arterial elasticity while moderately regulating platelet aggregation responses. By preserving vascular endothelial integrity, alleviating low-grade chronic vascular inflammation and mitigating oxidative-stress-induced damage, it delivers dietary nutritional support for cardiovascular metabolism.

 

S Equol Supplements

Equol, especially bioactive S-equol, serves as a core raw material for global women's-health dietary supplements. It is mainly targeted at consumers who cannot endogenously synthesize equol via gut microbiota. It is predominantly applied for comprehensive menopausal support, helping relieve menopause-related discomforts such as hot flashes, night sweats, mood irritability and sleep disturbances. It also delivers auxiliary benefits including protection against bone loss, vascular endothelial maintenance and oral anti-aging for skin. End-market products are mostly available in capsules and tablets, frequently formulated with vitamins, minerals and plant extracts, with a daily dosage ranging from 10 mg to 30 mg. Japan boasts the most mature commercialized market for this ingredient.

S Equol in Skincare Products

With its antioxidant, anti-inflammatory and collagen-regulating properties in fibroblasts, equol finds applications in two streams: topical skincare and oral nutricosmetics. For topical use, it functions as a premium anti-aging active ingredient added into serums and repair creams at a typical formulation dosage of 0.05-0.2%. It inhibits UV-induced ROS and MMP-1 collagen-degrading enzymes, mitigating photo-aging damage and improving skin sagging and fine lines. Oral nutricosmetics overlap with the dietary-supplement sector, enhancing skin elasticity and moisture content through internal administration. Being highly lipophilic, this ingredient requires solubilization treatment in formulations and light-protected storage.

Is S-equol safe? At the generally recommended dosage, S-equol is generally well-tolerated. However, potential side-effects still exist. Some individuals may experience mild gastrointestinal discomfort such as bloating, nausea and diarrhea, while a small number of people may suffer from headaches and breast tenderness. Given its weak estrogenic activity, individuals at high risk of estrogen-related cancers, pregnant and breastfeeding women should avoid self-supplementation.

Long-term intake at high doses may disrupt internal hormonal balance. Therefore, it should be taken appropriately based on personal conditions, and blind long-term high-dose use is not advised.

Healthkintai^® is a professional supplier integrating R&D, production and sales. We supply low price s equol powder with purity above 98%, stable quality to well meet your formulation requirements. Customized services are available, including particle size adjustment, compound formula and small-batch trial orders.

We can provide full set of technical documents such as COA, TDS, HPLC test reports, together with GMP-related compliance certificates to guarantee traceability and import-export compliance. Feel free to contact us at health@kintaibio.com for samples, quotation and further project discussion.

Hot Tags: s equol powder, China s equol powder manufacturers, suppliers, factory